These results, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,two aid the notion of focusing on ACKR3 as a singular solution to modulate the opioid program, which could open new therapeutic avenues for opioid-rela